Dangerous Drugs and Medical Devices
Metal-on-Metal Prosthetic Hips
According to the U.S. Food and Drug Administration (“FDA”), metal-on-metal hip implants have unique risks not associated with other types of hip implants. For example, in metal-on-metal hip implants, friction between the ball and cup can release tiny metal particles into the space around the implant.
Pradaxa is known to cause severe bleeding events that may lead to disabling, life-threatening or even fatal outcomes including heart attack and stroke. Additionally, although it is intended to prevent blood clots, Pradaxa may actually cause a particularly dangerous type of blood clot in the spinal cord.
Invokana was first approved by the U.S. Food and Drug Administration (“FDA”) in March 2013. Just two years later, in May 2015, the FDA issued a drug safety communication warning patients and doctors that Invokana and other SGLT2 inhibitors may lead to a serious condition called diabetic ketoacidosis (DKA).